Evidence map›Paper›PMID 38932390›Full record

ArticleVaccines2024

Identifying Key Drivers of Efficient B Cell Responses: On the Role of T Help, Antigen-Organization, and Toll-like Receptor Stimulation for Generating a Neutralizing Anti-Dengue Virus Response.

Jan M Sobczak, Irena Barkovska, Ina Balke, Dominik A Rothen, Mona O Mohsen, Dace Skrastina, Anete Ogrina, Byron Martina, Juris Jansons, Janis Bogans and 3 more

Abstract read
In one paragraph

Article in Vaccines, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Jan M SobczakDepartment of Immunology, University Clinic of Rheumatology and Immunology, Inselspital, CH-3010 Bern, Switzerland.ORCID 0000-0002-5271-7826
Irena BarkovskaLatvian Biomedical Research and Study Centre, LV-1067 Riga, Latvia.
Ina BalkeLatvian Biomedical Research and Study Centre, LV-1067 Riga, Latvia.ORCID 0000-0002-5171-7744
Dominik A RothenDepartment of Immunology, University Clinic of Rheumatology and Immunology, Inselspital, CH-3010 Bern, Switzerland.
Mona O MohsenDepartment of Immunology, University Clinic of Rheumatology and Immunology, Inselspital, CH-3010 Bern, Switzerland.
Dace SkrastinaLatvian Biomedical Research and Study Centre, LV-1067 Riga, Latvia.
Anete OgrinaLatvian Biomedical Research and Study Centre, LV-1067 Riga, Latvia.
Byron MartinaArtemis Bioservices, 2629 JD Delft, The Netherlands.
Juris JansonsLatvian Biomedical Research and Study Centre, LV-1067 Riga, Latvia.ORCID 0000-0003-0845-4392
Janis BogansLatvian Biomedical Research and Study Centre, LV-1067 Riga, Latvia.
Monique VogelDepartment of Immunology, University Clinic of Rheumatology and Immunology, Inselspital, CH-3010 Bern, Switzerland.ORCID 0000-0002-5219-4033
Martin F BachmannDepartment of Immunology, University Clinic of Rheumatology and Immunology, Inselspital, CH-3010 Bern, Switzerland.ORCID 0000-0003-4370-2099
Andris ZeltinsLatvian Biomedical Research and Study Centre, LV-1067 Riga, Latvia.

Funding

Innosuisse - Swiss Innovation Agency P2018-Eurostars-039Swiss National Science Foundation 310030_185114Swiss National Science Foundation IZRPZO_194968
6 · The paper itself

Abstract

T help (Th), stimulation of toll-like receptors (pathogen-associated molecular patterns, PAMPs), and antigen organization and repetitiveness (pathogen-associated structural patterns, PASPs) were shown numerous times to be important in driving B-cell and antibody responses. In this study, we dissected the individual contributions of these parameters using newly developed "Immune-tag" technology. As model antigens, we used eGFP and the third domain of the dengue virus 1 envelope protein (DV1 EDIII), the major target of virus-neutralizing antibodies. The respective proteins were expressed alone or genetically fused to the N-terminal fragment of the cucumber mosaic virus (CMV) capsid protein-nCMV, rendering the antigens oligomeric. In a step-by-step manner, RNA was attached as a PAMP, and/or a universal Th-cell epitope was genetically added for additional Th. Finally, a PASP was added to the constructs by displaying the antigens highly organized and repetitively on the surface of CMV-derived virus-like particles (CuMV VLPs). Sera from immunized mice demonstrated that each component contributed stepwise to the immunogenicity of both proteins. All components combined in the CuMV VLP platform induced by far the highest antibody responses. In addition, the DV1 EDIII induced high levels of DENV-1-neutralizing antibodies only if displayed on VLPs. Thus, combining multiple cues typically associated with viruses results in optimal antibody responses.

Indexed as

B-cell responsesdengue virus neutralizationnanostructuresvirus-like particles

Identifiers

PMID38932390
PMCPMC11209419

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.